GILLIAN SCHOENBAUER: Open Payments
NPI 1174963706 · BLOOMINGTON, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 10 payments from 8 companies in 2025. Trend: 2023 $59 · 2024 $220 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $56 |
| BridgeBio Pharma, Inc. | 3 | $46 |
| Boston Scientific Corporation | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: SAPIEN 3 Ultra RESILIA, Attruby, WATCHMAN FLX, JARDIANCE, Repatha, LifeVest, ELIQUIS, ENTRESTO.
Industry payments across MN — which companies pay providers there.
